FDA Inspection 991215 — H. Henry Li, MD
The FDA completed an inspection of H. Henry Li, MD on November 1, 2016 in Chevy Chase, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 1, 2016
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Chevy Chase, MD (United States)
Additional Details
Clinical Investigator (CI)